Migliori, G.B.; Pontali, E.; Sotgiu, G.; Centis, R.; D’Ambrosio, L.; Tiberi, S.; Tadolini, M.; Esposito, S.
Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review. Int. J. Mol. Sci. 2017, 18, 341.
https://doi.org/10.3390/ijms18020341
AMA Style
Migliori GB, Pontali E, Sotgiu G, Centis R, D’Ambrosio L, Tiberi S, Tadolini M, Esposito S.
Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review. International Journal of Molecular Sciences. 2017; 18(2):341.
https://doi.org/10.3390/ijms18020341
Chicago/Turabian Style
Migliori, Giovanni Battista, Emanuele Pontali, Giovanni Sotgiu, Rosella Centis, Lia D’Ambrosio, Simon Tiberi, Marina Tadolini, and Susanna Esposito.
2017. "Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review" International Journal of Molecular Sciences 18, no. 2: 341.
https://doi.org/10.3390/ijms18020341
APA Style
Migliori, G. B., Pontali, E., Sotgiu, G., Centis, R., D’Ambrosio, L., Tiberi, S., Tadolini, M., & Esposito, S.
(2017). Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review. International Journal of Molecular Sciences, 18(2), 341.
https://doi.org/10.3390/ijms18020341
